TTK Healthcare Limited
NSE: TTKHLTCAREINE910C01018·Diversified·www.ttkhealthcare.com ↗·Mcap ₹1,487 Cr·Listed 2015
₹1,031.10▼ ₹14.30  (−1.37%)
52W: ₹735 – ₹1,247 · Vol: 12.1K shares · Close 25 Sept
Set Alert

Quarterly results

standalone · as filed with NSE · Q1 FY27 back to Q1 FY19
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24Q4 FY23Q3 FY23Q2 FY23Q4 FY22Q3 FY22Q2 FY22Q1 FY22Q4 FY21Q3 FY21Q2 FY21Q1 FY21Q4 FY20Q3 FY20Q2 FY20Q1 FY20Q3 FY19Q2 FY19Q1 FY19
Revenue from operations258218209204226190205198208181184186202180183170159212206171181179160116137166165179149166173
Other income16.817.817.41917.918.717.817.71716.115.91614.615.611.811.15.24.533.73.42.52.21.92.72.221.91.71.91.8
Total expenses245210205201227181200193204173182180196169178170158200194166171171155121138162161174143157162
EBITDA14.7117.15.32.7127.78.26.912.45.39.51015.28.444.717.115.88.814.711.89−0.72.78.78.48.510.513.515.8
EBITDA margin5.7%5.1%3.4%2.6%1.2%6.3%3.8%4.1%3.3%6.9%2.9%5.1%5.0%8.4%4.6%2.3%3.0%8.1%7.6%5.2%8.1%6.6%5.7%-0.6%2.0%5.2%5.1%4.7%7.0%8.1%9.1%
Finance costs0.50.60.70.80.80.90.80.70.90.90.20.70.910.80.811.50.60.60.70.40.60.60.90.90.80.70.70.91
Depreciation2.12.12.22.22.22.22.122.13.33.33.33.23.13.23.33.13.33.33.33.43.43.43.53.63.73.63.53.53.53.6
Profit before tax28.929.514.121.317.721.822.623.240.824.217.721.620.626.816.210.95.816.817.58.514.110.615.3−2.90.96.466.181113
Tax7.67.83.60.94.75.65.969.264.85.556.34.231.64.64.72.53.72.9−15.5−0.50.51.92.32.43.14.35.1
Net profit21.321.810.520.41316.116.717.231.618.312.91615.716.9129.910.612.212.8610.37.730.8−2.40.44.53.83.64.96.77.9
Net margin8.3%10.0%5.0%10.0%5.7%8.5%8.2%8.7%15.2%10.1%7.0%8.6%7.8%9.4%6.6%5.8%6.7%5.7%6.2%3.5%5.7%4.3%19.3%-2.1%0.3%2.7%2.3%2.0%3.3%4.0%4.6%
EPS (₹)15.0615.407.4514.439.2011.4311.8412.1722.3512.939.1311.3311.0914.458.495.602.998.619.074.247.325.4421.80-1.700.303.172.682.583.464.715.58
Net profit YoY+63.7%+34.8%−37.1%+18.5%−58.8%−11.6%+29.8%+7.5%+101.5%+7.8%+7.5%+61.5%–+59.5%−1.4%−22.6%+2.6%+58.3%−58.4%+349.6%+2353.3%+71.7%+714.9%−166.0%–−8.3%−43.2%−53.8%–––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25FY24FY23FY22FY21FY20
Revenue from operations857801753725599637646
Other income72.271.362.648.316.3108.8
Total expenses843778731712593618635
EBITDA26.234.837.331.321.834.928.3
EBITDA margin3.1%4.3%5.0%4.3%3.6%5.5%4.4%
Finance costs2.93.32.85.23.22.23.3
Depreciation8.88.313.112.812.613.714.4
Profit before tax82.610884.161.624.837.119.4
Tax16.926.721.3176.3−9.47.1
Net profit65.781.762.864041.646.412.3
Net margin7.7%10.2%8.3%88.2%6.9%7.3%1.9%
EPS (₹)46.4857.7944.4731.6113.1032.878.72
Net profit YoY−19.6%+29.9%−90.2%+1438.2%−10.4%+277.0%–
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25FY24FY23FY22
Operating cash flow−21.1−4−4.9−26.145
Investing cash flow51.620.128.533−30.5
Financing cash flow−17.6−18.1−21.9−12.4−9.1
Capital expenditure5.812.810.411.76.5
Free cash flow (CFO − capex)−27−16.8−15.3−37.838.5

Net profit trend

annual, ₹ crore
FY21
₹46.4
FY22
₹41.6−10%
FY23
₹640+1438%
FY24
₹62.8−90%
FY25
₹81.7+30%
FY26
₹65.7−20%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Standalone6 Aug 2026PDF on NSE XBRL
Q4 FY26Standalone · audited30 May 2026PDF on NSE XBRL
Q3 FY26Standalone22 Jan 2026PDF on NSE XBRL
Q2 FY26Standalone17 Oct 2025PDF on NSE XBRL
Q1 FY26Standalone4 Aug 2025 PDF XBRL
Q4 FY25Standalone · audited23 May 2025 PDF XBRL
Q3 FY25Standalone24 Jan 2025PDF on NSE XBRL
Q2 FY25Standalone25 Oct 2024PDF on NSE XBRL
Q1 FY25Standalone2 Aug 2024PDF on NSE XBRL
Q4 FY24Standalone · audited24 May 2024PDF on NSE XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 18.0×19.7×
P/B5Y avg 1.63×1.31×
ROEFY26, on average equity6.0%
Net margin7.7%
Debt / equity0.02×
Revenue CAGR (3Y)5.7%
Profit CAGR (3Y)-53.2%
EPS (TTM)₹52.34
Market cap₹1,457 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
1.31×
vs 8-point avg 1.63× (−20%)
0.94× low1.63× avg2.28× high
History points are balance-sheet dates (2022 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹1,329 Cr+4%
Net worth₹1,115 Cr+5%
Total borrowings₹24 Cr−1%
Cash & bank balances₹22 Cr+143%
Investments₹9 Cr−23%
Inventories₹109 Cr+0%
Trade receivables₹111 Cr+22%
Trade payables₹91 Cr−15%
Change vs the same date a year earlier.
Revenue mix FY26
Consumer Products28.1%result ₹18.4 Cr
Protective Devices25.3%result ₹−10.5 Cr
Foods17.6%result ₹13.4 Cr
Animal Welfare16.5%result ₹11.9 Cr
Medical Devices12.5%result ₹22.5 Cr
Others0.0%result ₹0.4 Cr
Segment revenue as reported, before inter-segment eliminations.
Shareholding 30 Jun 2026
%Jun 26Mar 26Dec 25Sept 25Jun 25Mar 25Dec 24Sept 24Jun 24Mar 24Dec 23Sept 23
Promoter74.5674.5674.5674.5674.5674.5674.5674.5674.5674.5674.5674.56
FII1.861.901.891.901.891.901.901.901.871.850.001.85
DII2.191.111.081.181.181.141.141.141.141.144.993.22
of which MF0.000.000.000.000.04–––––––
Retail14.8115.6615.8015.8916.0116.1216.1916.0217.8117.9816.7216.47
Other public6.586.776.676.476.366.286.216.384.624.473.733.90
22,809 shareholders · NSE shareholding pattern filings.